article thumbnail

Leading clinical dose companies in contract marketing

Pharmaceutical Technology

Pharmaceutical drug research and development (R&D) activities are capital-intensive, which makes the outsourcing of clinical dose manufacturing and marketing popular. Find the leading clinical dose companies in contract marketing. Prospects of clinical dose companies in contract marketing.

Marketing 100
article thumbnail

Russia: Pfizer stops clinical trials, Bayer halts investment projects

BioPharma Reporter

Pfizer Inc says it will maintain its supply of medicines to Russia but it will not initiate new clinical trials in the country, while Bayer is suspending investment projects and new-business development in that market.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

eClinical Provider Crucial Data Solutions Appoints Brian Dufresne as SVP Business Development

Crucial Data Soutions

After experiencing significant growth in the clinical trial solutions market in 2021, Crucial Data Solutions has added another industry veteran to its leadership team. Founded in 2010, Crucial Data Solutions (CDS) provides the most innovative low-code/no-code data and clinical trial management technology on the market today.

article thumbnail

Leading API chemical companies in contract marketing

Pharmaceutical Technology

Contract marketing companies offer various marketing services that connect suitable strategies with customers at different points in the product lifecycle, helping to increase the customer base and thus revenue. Finding the top API chemical companies in contract marketing.

Marketing 130
article thumbnail

Pfizer vaults into sickle cell market as GBT deal confirmed

pharmaphorum

As we reported this morning, the deal gives Pfizer already-approved SCD therapy Oxbryta (voxelator) – which industry watchers reckon could see a dramatic uptick in sales with Pfizer’s marketing muscle – plus a phase 3 antibody candidate, a phase 1 follow-up to Oxbryta that could offer improved dosing.

Marketing 111
article thumbnail

Innovative Program Expands Clinical Trial Workforce, Patient Outreach in Hispanic Communities

ACRP blog

Just ask Michaele Linden-Johnson, FACHE, MBA, LCSW, director of clinical trials and business development at the Medical Center of the Americas (MCA) Foundation Cardwell Collaborative in El Paso, Texas. We’re all about developing a workforce designed to reflect our patient population,” Linden-Johnson says.

article thumbnail

Increasing patient engagement with UK clinical trials

pharmaphorum

Pharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so can have huge benefits for the sustainability and success of research. Gaining patient input on marketing and recruitment materials. How the NIHR’s Patient Engagement in Clinical Development service can help.